2024-11-14T16:21:32-05:00 2023-12-31 680586549 Clear View Business Solutions 7530 N La Cholla Blvd Tucson AZ 85741 990EZ 2023-01-01 954070206 Warner House Inc WARN 12112 N Rancho Vistoso Blvd 150-351 Oro Valley AZ 85755 Beverly Sommer President and C 7144412600 2024-11-11 true true Deborah Elver P00461579 5205440177 2024-11-14 2023 2024-10-15 13:58:12Z X X X warnerhouse.com X X 24429 X 500 23929 24429 2538 11520 429 6938 21425 3004 18662 21666 X 18662 22489 0 0 0 0 18662 22489 0 823 18662 21666 X See Sch O See Sch O 3045 3045 Jill Philips Cheif Financial Officer 1.00 0 0 0 Beverly Sommer President and CEO 25.00 0 0 0 Karin Johnson Vice President and Secretary 1.00 0 0 0 false false false false false false false false false CA Beverly Sommer 12112 N Rancho Vistoso Blvd 150-351 Oro Valley AZ 85755 7144412600 false false false false false false false false false false false NONE NONE true X 500 500 24638 23028 29924 24357 22083 124030 24638 23028 29924 24357 22583 124530 124530 24638 23028 29924 24357 22583 124530 1.00000 1.00000 0.00000 0.00000 X General explanation attachment Board Members are parents of children with Down Syndrome and are very active in attending functions, meetings, schools, events, etc. with agendas of services to people with Down Syndrome and are public relations representatives for Warner House. Description of other expenses Part I line 16 Description AmountAdmin Fees 144Bank Charges 168Office Supplies 342Phone and Internet 1,408Storage 3,300Telephone 368Website 1,208 Description of total liabilities Part II line 26 Category Beginning of Year End of YearCredit Card 0 823 Personal benefit contract statement Part V Part V, Information regarding personal benefit contracts: The organization did not, during the year, receive any funds, directly, or indirectly, to pay premiums on a personal benefit contract. The organization, did not, during the year, pay any premiums, directly, or in directly, on a personal benefit contract. Part III response or note to any other line in Part III Part III. Primary exempt purpose: Further the research in Down syndrome thru education, parental advisors, and maintaining a website. Provision of metabolic supplements to children & adults with Down syndrome.Part III, Line 28, Program Service Accomplishments: Amyloid-B Level Testing in Young Adults with Down Syndrome on Long-Term Antioxidant Treatment A study has been scheduled for spring 2024 that will quantify blood plasma amyloid beta levels of clients of Warner House, Inc. who have been taking the metabolic supplement HAP Caps designed by Dr. Warner to combat the deteriorating symptoms of Down Syndrome (DS). Without the proper amount of catalase, the conversion of superoxide dismutase (SOD) will not transfer into the next oxidative state. The deficiency results in an accumulation of SOD in each cell of the body in DS. Formulated to reduce levels of SOD, HAP Caps also aid cellular defenses with the use of antioxidants, vitamins, minerals, amino acids and enzymes.Results of studies of patients taking HAP Caps show: increased height and musculature; more normalized facial features; improved cognition.Although Alzheimers Disease (AD) affects about 1 in 10 people over the age of 65, it is found in a substantially greater percentage in people with DS and at a much earlier age. AD and DS are both found on the 21st chromosome. It Is now possible to show a diagnosis of AD by measuring the amount of amyloid beta in the blood. Results of the study will show if amyloid beta levels in participants who take HAP Caps are significantly reduced compared to amyloid beta levels in the blood of people with DS who have not taken the formula. This is key in identifying HAP Caps as a prevention or delay of onset of AD symptoms. This could have a profound impact both in people with Down Syndrome as well as the general population.